ArticleMolecular cancer therapeutics2012

Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9.

Nathan G Dolloff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.